<DOC>
<DOCNO>
EP-0013817
</DOCNO>
<TEXT>
<DATE>
19800806
</DATE>
<IPC-CLASSIFICATIONS>
C07D-233/00 A61P-25/00 C07D-401/00 C07D-401/12 C07D-409/12 C07D-405/00 A61K-31/443 <main>C07D-409/12</main> A61P-25/20 A61K-31/4427 C07D-405/12 C07D-409/00 A61K-31/44 C07D-233/88 A61K-31/4433 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
1-imidazol-2-ylidene-3-thienyl-urea derivatives, processes therefor, and pharmaceutical compositions.
</TITLE>
<APPLICANT>
ici america incus<sep>ici americas inc<sep>ici americas inc.concord pike &amp; new murphy roadwilmington delaware 19897us<sep>ici americas inc<sep>
</APPLICANT>
<INVENTOR>
bare thomas michael<sep>bare, thomas michael<sep>bare, thomas michael1078 windy knoll roadwest chester, pa 19380us<sep>bare, thomas michael<sep>bare, thomas michael1078 windy knoll roadwest chester, pa 19380us<sep>
</INVENTOR>
<ABSTRACT>
compounds of the formula:    wherein r stands for a lower alkyl radical and z stands for a  pyridyl, thienyl or furyl radical, any of which may optionally be  substituted with 1 to 3 defined substituents, and salts there­ of.  two processes for the manufacture of said compounds.   pharmaceutical compositions comprising any one of said  compounds together with a pharmaceutically-acceptable dil­ uent or carrier.  the compounds exhibit anxiolytic activity,  and some of them block acid secretions.  
</ABSTRACT>
</TEXT>
</DOC>
